Immunic | VTL - Operating Expenses


Immunic reported $23.33M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Alterity Therapeutics Limited AUD 8.67M 893.38K Dec/2025
BioMarin Pharmaceutical USD 819.04M 5.5B Sep/2026
Cipla INR 63.61B 1.3B Sep/2026
Clal Biotechnology ILS 5.15M 9.47M Dec/2022
Compugen USD 11.44M 246K Jun/2026
CSL USD 5.7B 2.82B Dec/2025
Enanta Pharmaceuticals USD 126.59M 346.51M Dec/2025
Grifols EUR 1.99B 217.4M Dec/2025
Immunic USD 23.33M 2.67M Dec/2025
Insmed USD 606.26M 79.46M Sep/2026
Omeros USD 59.16M 20.13M Jun/2024
OraSure Technologies USD 40.35M 2.45M Dec/2025
Quidel USD 606.8M 39.4M Sep/2026
Ultragenyx Pharmaceutical USD 283M 6M Sep/2026
United Therapeutics USD 6.28B 124.3M Sep/2026